MetLife Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-37,639
| Closed | -$677K | – | 2361 |
|
|
2020
Q2 | $677K | Buy |
37,639
+4,664
| +14% | +$83.9K | 0.01% | 1215 |
|
|
2020
Q1 | $235K | Hold |
32,975
| – | – | ﹤0.01% | 1604 |
|
|
2019
Q4 | $787K | Hold |
32,975
| – | – | 0.01% | 1218 |
|
|
2019
Q3 | $884K | Buy |
32,975
+3,043
| +10% | +$81.6K | 0.01% | 1131 |
|
|
2019
Q2 | $812K | Hold |
29,932
| – | – | 0.01% | 1212 |
|
|
2019
Q1 | $1.04M | Hold |
29,932
| – | – | 0.01% | 1066 |
|
|
2018
Q4 | $584K | Hold |
29,932
| – | – | 0.01% | 1270 |
|
|
2018
Q3 | $797K | Hold |
29,932
| – | – | 0.01% | 1245 |
|
|
2018
Q2 | $1.13M | Buy |
29,932
+4,318
| +17% | +$163K | 0.01% | 974 |
|
|
2018
Q1 | $837K | Hold |
25,614
| – | – | 0.01% | 1086 |
|
|
2017
Q4 | $1.25M | Buy |
+25,614
| New | +$1.25M | 0.01% | 944 |
|